Supplementary Figure S1 from First-in-Maintenance Therapy for Localized High-Grade Osteosarcoma: An Open-Label Phase I/II Trial of the Anti–PD-L1 Antibody ZKAB001

<p>Kaplan-Meier curves for Event-free Survival (EFS) in each dose group</p>

Furkejuvvon:

Bibliográfalaš dieđut
Váldodahkki:	Yan Zhou (15053225) (author)
Eará dahkkit:	Qingcheng Yang (15053228) (author), Yang Dong (15053231) (author), Tong Ji (15053234) (author), Bing Zhang (15053237) (author), Cheng Yang (15053240) (author), Shuier Zheng (15053243) (author), Lina Tang (15053246) (author), Chenliang Zhou (15053249) (author), Guowei Qian (15053252) (author), Yujing Huang (15053255) (author), Wenxi Yu (15053258) (author), Hongtao Li (15053261) (author), Yonggang Wang (15053264) (author), Aina He (15053267) (author), Zan Shen (15053270) (author), Qiyuan Bao (15053273) (author), Yingqi Hua (15053276) (author), Hongyu Bai (15053279) (author), Jiayi Zhao (15053282) (author), Xiaoyi Li (15053285) (author), Xiangrong Dai (15047025) (author), Jianjun Zhang (15053288) (author), Haiyan Hu (15053291) (author), Yang Yao (15053294) (author)
Almmustuhtton:	2025
Fáttát:	Cancer Therapeutic Research and Development Clinical Research and Trials Chemotherapy Clinical-Stage Research Sarcomas Osteosarcoma
Fáddágilkorat:	Lasit fáddágilkoriid Eai fáddágilkorat, Lasit vuosttaš fáddágilkora!

Geahča maid